Affiliation:
1. Service of Microbiology, Hospital Prínceps d'Espanya, Ciutat Sanitària i Universitària de Bellvitge, Barcelona, Spain.
Abstract
A total of 410 strains of viridans group streptococci isolated consecutively from blood were tested by the microdilution method for in vitro susceptibility to 22 beta-lactam antibiotics. One hundred thirty-eight strains (33.6%) were resistant to penicillin with a MIC range of 0.25 to 8 micrograms/ml. MICs of all beta-lactam agents tested were higher for penicillin-resistant strains than for susceptible strains. These antibiotics were classified into three groups according to their in vitro activities (MICs at which 50 and 90% of the isolates are inhibited). Beta-Lactams of the first group (these included imipenem, cefpirome, FK-037, cefditoren, cefotaxime, ceftriaxone, and cefepime) showed activities higher than or similar to that of penicillin against penicillin-resistant viridans group streptococci. However, 80% of highly penicillin-resistant Streptococcus mitis organisms required cefotaxime and ceftriaxone MICs of > or = 2 micrograms/ml (range, 2 to 16 micrograms/ml). Beta-Lactams of the second group (cefpodoxime, ampicillin, amoxicillin-clavulanate, piperacillin, and cefuroxime) showed lower activities than penicillin. Finally, antibiotics of the third group (cephalothin, oxacillin, ceftazidime, cefixime, cefaclor, cefetamet, cefadroxil, cephalexin, and ceftibuten) showed poor in vitro activities. Therefore, some of the beta-lactam agents included in the first group could be an acceptable alternative in the treatment of serious infections due to strains highly resistant to penicillin, although clinical experience is needed.
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology
Reference39 articles.
1. Alcaide F. J. Liares J. Ayats T. Alonso M. A. Domínguez J. Salvá J. Niubó and R. Martín. 1993. In vitro activity of 17 ~-lactam antibiotics against ``viridans'' streptococci isolated from blood (1990-92) abstr. 1017. In Program and abstracts of the 6th European Congress of Clinical Microbiology and Infectious Diseases. European Society of Clinical Microbiology and Infectious Diseases Munich.
2. Streptococcal and enterococcal bacteremia in patients with cancer;Awada A.;Clin. Infect. Dis.,1992
3. Infective endocarditis-a 25-year overview of diagnosis and therapy;Branderburg R. O.;J. Am. Coll. Cardiol.,1983
4. Non-group D alphahemolytic streptococci: new neonatal pathogens;Broughton R. A.;J. Pediatr.,1981
5. Viridans streptococcal bacteraemia in patients with haematological and solid malignancies;Burden A. D.;Eur. J. Cancer,1991
Cited by
99 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献